CNO — California Nanotechnologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.91m
- CA$18.40m
- $6.22m
Annual cashflow statement for California Nanotechnologies, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.121 | 0.201 | 0.08 | 0.382 | -0.158 |
| Depreciation | |||||
| Non-Cash Items | -0.051 | 0.023 | 0.158 | 0.545 | 1.89 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.066 | -0.209 | 0.243 | -0.968 | 0.61 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.025 | 0.144 | 0.623 | 0.104 | 2.92 |
| Capital Expenditures | — | -0.008 | -0.086 | -0.014 | -2.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.015 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.008 | -0.086 | -0.014 | -2.11 |
| Financing Cash Flow Items | — | -0.061 | -0.197 | -0.088 | -0.049 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.047 | -0.105 | -0.373 | 0.535 | -1.12 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.022 | 0.031 | 0.165 | 0.625 | -0.308 |